{"entity":{"type":"insider","cik":"0001725743","url":"/insider/0001725743","json_url":"/insider/0001725743.json","name":"Yalamanchi Naveen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2018-08-03","last":"2021-05-13","span_basis":"filed_date"},"name_variants":[{"name":"Yalamanchi Naveen","source":"filing","n_filings":5,"first_seen":"2018-08-03","last_seen":"2021-05-13"}],"transactions":[{"id":5296080,"accession":"0001493152-21-011359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-011359","line_url":"/filing/0001493152-21-011359#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":null,"owner_name":"WONG RODERICK; RTW INVESTMENTS, LP; Yalamanchi Naveen","owner_display_name":"WONG RODERICK","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":725000.0,"shares_display":"725,000","price_per_share":40.0324,"price_display":"40.03","price_state":"stated","total_value":29023490.0,"total_display":"29,023,490.00","total_whole":"29,023,490","shares_owned_after":15460119.0,"shares_owned_after_display":"15,460,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":3304240,"accession":"0001493152-20-023575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-023575","line_url":"/filing/0001493152-20-023575#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":null,"owner_name":"WONG RODERICK; Yalamanchi Naveen; RTW INVESTMENTS, LP","owner_display_name":"WONG RODERICK","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":247720.0,"shares_display":"247,720","price_per_share":56.0,"price_display":"56.00","price_state":"stated","total_value":13872320.0,"total_display":"13,872,320.00","total_whole":"13,872,320","shares_owned_after":17530044.0,"shares_owned_after_display":"17,530,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-10","filed_date":"2020-12-14","scope":"insider"},{"id":8530508,"accession":"0001493152-19-019095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-19-019095","line_url":"/filing/0001493152-19-019095#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":null,"owner_name":"Yalamanchi Naveen; WONG RODERICK; RTW INVESTMENTS, LP","owner_display_name":"Yalamanchi Naveen","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":22.25,"price_display":"22.25","price_state":"stated","total_value":5006250.0,"total_display":"5,006,250.00","total_whole":"5,006,250","shares_owned_after":17282324.0,"shares_owned_after_display":"17,282,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-12","scope":"insider"},{"id":8621667,"accession":"0001140361-19-007331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-19-007331","line_url":"/filing/0001140361-19-007331#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":null,"owner_name":"RTW INVESTMENTS, LP; WONG RODERICK; Yalamanchi Naveen","owner_display_name":"RTW INVESTMENTS, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550005.0,"shares_display":"550,005","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":9625087.5,"total_display":"9,625,087.50","total_whole":"9,625,088","shares_owned_after":17057324.0,"shares_owned_after_display":"17,057,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-16","filed_date":"2019-04-18","scope":"insider"},{"id":6577492,"accession":"0001140361-18-035455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-035455","line_url":"/filing/0001140361-18-035455#line-1","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"ROCKET PHARMACEUTICALS, INC.","issuer_ticker":"RCKT","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001725743","owner_name":"Yalamanchi Naveen","owner_display_name":"Yalamanchi Naveen","owner_url":"/insider/0001725743","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":637.0,"shares_display":"637","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":14014.0,"total_display":"14,014.00","total_whole":"14,014","shares_owned_after":113641.0,"shares_owned_after_display":"113,641","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001281895","name":"ROCKET PHARMACEUTICALS, INC.","url":"/issuer/0001281895","role":"Director","n_filings":5,"first_seen":"2018-08-03","last_seen":"2021-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001725743","retrieved_at":"2026-08-26T14:18:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}